
1. nat commun. 2020 apr 14;11(1):1780. doi: 10.1038/s41467-020-15440-4.

pan-active imidazolopiperazine antimalarials target plasmodium falciparum
intracellular secretory pathway.

lamonte gm(1), rocamora f(1), marapana ds(2)(3), gn√§dig nf(4), ottilie s(1), luth
mr(1), worgall ts(5), goldgof gm(1)(6), mohunlal r(4)(7), santha kumar tr(4),
thompson jk(2)(3), vigil e(1), yang j(1), hutson d(1), johnson t(8), huang j(8), 
williams rm(1), zou by(1), cheung al(1), kumar p(1), egan tj(7)(9), lee mcs(10), 
siegel d(8), cowman af(2)(3), fidock da(4)(11), winzeler ea(12).

author information: 
(1)department pediatrics, school medicine, university california, san
diego, la jolla, ca, 92093, usa.
(2)division infection immunity, walter eliza hall institute for
medical research, parkville, vic, 3052, australia.
(3)department medical biology, university melbourne, parkville, vic, 3010, 
australia.
(4)department microbiology & immunology, columbia university irving medical
center, new york, ny, 10032, usa.
(5)department pathology cell biology, columbia university irving medical
center, new york, ny, 10032, usa.
(6)department laboratory medicine, university california, san francisco,
ca, 94143, usa.
(7)department chemistry, university cape town, rondebosch, 7700, south
africa.
(8)skaggs school pharmacy pharmaceutical sciences, university of
california, san diego, la jolla, ca, 92093, usa.
(9)institute infectious disease molecular medicine, university cape
town, rondebosch, 7700, south africa.
(10)parasites microbes programme, wellcome sanger institute, hinxton, cb10
1sa, uk.
(11)division infectious diseases, department medicine, columbia university 
irving medical center, new york, ny, 10032, usa.
(12)department pediatrics, school medicine, university california, san
diego, la jolla, ca, 92093, usa. ewinzeler@ucsd.edu.

a promising new compound class treating human malaria the
imidazolopiperazines (izp) class. izp compounds kaf156 (ganaplacide) gnf179
are effective plasmodium symptomatic asexual blood-stage infections, 
are able prevent transmission block infection animal models. but
despite identification resistance mechanisms p. falciparum, mode of
action izps remains unknown. investigate, combine vitro
evolution genome analysis saccharomyces cerevisiae molecular,
metabolomic, chemogenomic methods p. falciparum. findings reveal 
izp-resistant s. cerevisiae clones carry mutations genes involved in
endoplasmic reticulum (er)-based lipid homeostasis autophagy. plasmodium, 
izps inhibit protein trafficking, block establishment new permeation
pathways, cause er expansion. data highlight mechanism blocking
parasite development distinct standard compounds used to
treat malaria, demonstrate potential izps studying er-dependent
protein processing.

doi: 10.1038/s41467-020-15440-4 
pmcid: pmc7156427
pmid: 32286267  [indexed medline]

